Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS) in Couples With High Sperm DNA Fragmentation Undergoing ICSI: Which Approach is Better

NCT05866484 is registered in ClinicalTrials.gov with Clinique Ovo as lead sponsor.

NCT NCT05866484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS) in Couples With High Sperm DNA Fragmentation Undergoing ICSI: Which Approach is Better
Lead sponsor
Clinique Ovo
Phase
Observational
Overall status
Completed
Start date
May 10, 2023
Completion date
May 31, 2024
Enrollment
280 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

azoospermia, infertility, male, reproductive disorder